Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 8, 2007, Pages 785-790

  Masuda, Muneyuki ^a   Ruan, Hong Ying ^b   Ito, Aya ^b   Nakashima, Torahiko ^b   Toh, Satoshi ^c   Wakasaki, Takahiro ^b   Yasumatsu, Ryuji ^b   Kutratomi, Yuichiro ^d   Komune, Shizuo ^b   Weinstein, I Bernard ^c  

^a KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c College of Physicians and Surgeons ^*  (United States)

^d SAGA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; HNSCC; Stat3; VEGF

Indexed keywords

STAT3 PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STAT3 TRANSCRIPTION FACTOR; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547975508     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.10.007     Document Type: Article

References (25)

1. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 3 (1996) 353-364
2. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 7 (1999) 527-543
3. Rak J., Yu J.L., Klement G., and Kerbel R.S. Oncogenes and angiogenesis: signaling three-dimensional tumor growth. J Invest Dermatol Symp Proc 5 1 (2000) 24-33
4. Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 6 (2003) 401-410
5. Gong W., Wang L., Yao J.C., Ajani J.A., Wei D., Aldape K.D., et al. Expression of activated signal transducers and activators of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 11 4 (2005) 1386-1393
6. Tanaka F., Otake Y., Yanagihara K., Kawano Y., Miyahara R., Li M., et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 7 11 (2001) 3410-3415
7. Sauter E.R., Nesbit M., Watson J.C., Klein_Szanto A., Litwin S., and Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5 4 (1999) 775-782
8. Smith B.D., Smith G.L., Carter D., Sasaki C.T., and Haffty B.G. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18 10 (2000) 2046-2052
9. Lopez de Cicco R., Watson J.C., Bassi D.E., Litwin S., and Klein-Szanto A.J. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. Clin Cancer Res 10 13 (2004) 4480-4488
10. Yu H., and Jove R. The STATs of cancer-new molecular targets come of age. Nature Rev Cancer 4 2 (2004) 97-105
11. Song J.I., and Grandis J.R. STAT signaling in head and neck cancer. Oncogene 19 21 (2000) 2489-2495
12. Masuda M., Toh S., Koike K., Kuratomi Y., Suzui M., Deguchi A., et al. The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil. Jpn J Cancer Res 93 3 (2002) 329-339
13. Masuda M., Suzui M., Yasumatu R., Nakashima T., Kuratomi Y., Azuma K., et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62 12 (2002) 3351-3355
14. Xi S., Gooding W.E., and Grandis J.R. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 24 6 (2005) 970-979
15. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 13 (2002) 2000-2008
16. Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Lai K.B., Lee C.N., et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22 10 (2003) 1517-1527
17. Wei D., Le X., Zheng L., Wang L., Frey J.A., Gao A.C., et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22 3 (2003) 319-329
18. Masuda M., Suzui M., and Weinstein I.B. Effects of epigallocatechin-3-gallate (EGCG) on growth, epidermal growth factor receptor signaling pathways, gene expression and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7 (2001) 4220-4229
19. Masuda M., Suzui M., Lim J.T., Deguchi A., Soh J.W., and Weinstein I.B. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2 6 (2002) 350-359
20. Masuda M., Suzui M., Lim J.T., Soh J.W., and Weinstein I.B. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 9 9 (2003) 3486-3491
21. Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kiuchi N., et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. Embo J 15 14 (1996) 3651-3658
22. Minchenko A., Salceda S., Bauer T., and Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40 1 (1994) 35-39
23. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D_Acquisto F., et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95 1 (2000) 189-197
24. Myoung H., Hong S.D., Kim Y.Y., Hong S.P., and Kim M.J. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma. Cancer Lett 163 2 (2001) 191-200
25. Yasumatsu R., Nakashima T., Masuda M., Ito A., Kuratomi Y., Nakagawa T., et al. Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 130 10 (2004) 567-573